We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
-2.36%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$58.2B
AUM Growth
-$3.82B
(-6.2%)
Cap. Flow
-$2.56B
Cap. Flow
% of AUM
-4.4%
Top 10 Holdings %
Top 10 Hldgs %
42.63%
Holding
1,057
New
84
Increased
369
Reduced
421
Closed
149
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$516M |
| 2 |
Walt Disney
DIS
|
+$214M |
| 3 |
O'Reilly Automotive
ORLY
|
+$143M |
| 4 |
Nike
NKE
|
+$66.8M |
| 5 |
Arm
ARM
|
+$58.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America Series L
BAC.PRL
|
+$724M |
| 2 |
NVIDIA
NVDA
|
+$604M |
| 3 |
Meta Platforms (Facebook)
META
|
+$458M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$118M |
| 5 |
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.13% |
| 2 | Communication Services | 16.86% |
| 3 | Consumer Discretionary | 16.15% |
| 4 | Healthcare | 13.57% |
| 5 | Financials | 10.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Acadia Healthcare
ACHC
$2.94B
| $54.4M | 0.09% |
773,595
-11,452
| -1% | -$856K |
|
102
Evertec
EVTC
$1.78B
| $54M | 0.09% |
1,452,050
+202,757
| +16% | +$7.9M |
|
103
Applied Industrial Technologies
AIT
$13.3B
| $53.9M | 0.09% |
348,421
-10,877
| -3% | -$1.63M |
|
104
Churchill Downs
CHDN
$6.12B
| $52.9M | 0.09% |
455,761
-79,234
| -15% | -$9.81M |
|
105
Ambev
ABEV
$46.4B
| $51.9M | 0.09% |
20,133,047
-718,479
| -3% | -$2.08M |
|
106
Veeva Systems
VEEV
$37.4B
| $50.5M | 0.09% |
248,318
-10,235
| -4% | -$2.06M |
|
107
CRISPR Therapeutics
CRSP
$5.17B
| $49.8M | 0.09% |
1,096,354
-51,575
| -4% | -$2.66M |
|
108
Huron Consulting
HURN
$2.42B
| $49.4M | 0.08% |
474,207
-14,801
| -3% | -$1.41M |
|
109
WEX
WEX
$6.31B
| $49.1M | 0.08% |
260,906
-4,994
| -2% | -$964K |
|
110
Supernus Pharmaceuticals
SUPN
$2.77B
| $47.7M | 0.08% |
1,730,269
+136,964
| +9% | +$4.17M |
|
111
MSCI
MSCI
$40.9B
| $47.6M | 0.08% |
92,698
-2,184
| -2% | -$1.15M |
|
112
LivaNova
LIVN
$4.2B
| $46.5M | 0.08% |
879,740
+208,755
| +31% | +$11.4M |
|
113
Columbia Sportswear
COLM
$2.94B
| $46.2M | 0.08% |
624,044
-8,375
| -1% | -$623K |
|
114
Tidewater
TDW
$4.12B
| $45.2M | 0.08% |
635,763
+16,102
| +3% | +$1.02M |
|
115
The Ensign Group
ENSG
$10.7B
| $44.9M | 0.08% |
482,965
-34,303
| -7% | -$3.25M |
|
116
Installed Building Products
IBP
$6.49B
| $44.9M | 0.08% |
359,223
-11,231
| -3% | -$1.59M |
|
117
PJT Partners
PJT
$4.38B
| $44.3M | 0.08% |
558,137
-17,388
| -3% | -$1.34M |
|
118
Procept Biorobotics
PRCT
$1.17B
| $44.1M | 0.08% |
1,345,454
+636,750
| +90% | +$21.7M |
|
|
VTYX
119
DELISTED
Ventyx Biosciences
VTYX
| $43.7M | 0.08% |
1,257,973
+259,736
| +26% | +$8.98M |
|
120
Tenable Holdings
TENB
$4.01B
| $43.5M | 0.07% |
972,017
+52,021
| +6% | +$2.34M |
|
121
Varonis Systems
VRNS
$5B
| $43.5M | 0.07% |
1,424,248
+329,045
| +30% | +$9.72M |
|
122
Kadant
KAI
$3.99B
| $43M | 0.07% |
190,502
-12,187
| -6% | -$2.64M |
|
123
Onto Innovation
ONTO
$15.3B
| $42.8M | 0.07% |
335,290
+38,278
| +13% | +$4.55M |
|
124
Flywire
FLYW
$2.16B
| $42.4M | 0.07% |
1,330,360
+704,938
| +113% | +$22.6M |
|
125
Boot Barn
BOOT
$4.95B
| $42.4M | 0.07% |
522,418
-55,172
| -10% | -$4.96M |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q3 2023 Portfolio in Review
As of Q3 2023, Loomis, Sayles & Company held 1,057 positions worth $58.2B, down 6.2% from $62B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Loomis, Sayles & Company withdrew a net $2.56B in Q3 2023, closing 149 positions and reducing 421 holdings. Its most notable exit was Callaway Golf Company, an estimated $62.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Communication Services and Consumer Discretionary.
Against the trend, Loomis, Sayles & Company opened a new position in Arm worth $57M.
- Loomis, Sayles & Company's largest Q3 2023 buy was Arm: 1,065,084 shares worth $57M.
- Loomis, Sayles & Company added most to Thermo Fisher Scientific in Q3 2023, an estimated $516M increase.
- Loomis, Sayles & Company's biggest Q3 2023 reduction was Bank of America Series L, cutting an estimated $724M.
- Loomis, Sayles & Company fully exited Callaway Golf Company in Q3 2023, selling an estimated $62.5M.
- Loomis, Sayles & Company's ten largest holdings make up 43% of its $58.2B portfolio in Q3 2023.
- Loomis, Sayles & Company opened 84 new positions and closed 149 in Q3 2023.
- Loomis, Sayles & Company's portfolio value fell 6.2% quarter-over-quarter to $58.2B.
Based on Loomis, Sayles & Company's 13F filing for Q3 2023, filed 9 Nov 2023.